MNG 00723 Report: AUSMED's Global Expansion in South Africa & China

This report, prepared for AUSMED, an Australian pharmaceutical company, examines the potential for international expansion into South Africa and China. It begins with an executive summary and table of contents, followed by a detailed analysis of the risks and opportunities in each country, utilizing PESTEL analysis to evaluate political, economic, social, technological, legal, and environmental factors. The report then recommends China as the more favorable destination, justifying this decision based on the analysis. Finally, it suggests Foreign Direct Investment as the most appropriate entry mode for AUSMED. The report concludes with references to support the analysis and recommendations.